Document:

Exhibit 10.2

 

REGISTRATION RIGHTS AGREEMENT

  

This Registration Rights Agreement (this “Agreement”)
is made and entered into as of February 18, 2022, by and between Entasis Therapeutics Holdings Inc., a Delaware corporation (the
 “Company”), and Innoviva Strategic Opportunities LLC (the “Holder”). The Company and the Holder
are referred to each as a “Party” and collectively herein as the “Parties.” Capitalized terms used
herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement.

 

In consideration of the mutual covenants and agreements
set forth herein and for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by each Party,
the Parties agree as follows:

 

1.            Definitions.
As used in this Agreement, the following terms shall have the respective meanings set forth
in this Section 1:

 

“Affiliate” means, with respect
to any Person, any other Person, that directly or indirectly, Controls or is Controlled by or is under common Control with, such Person;
provided, however, that for purposes of this Agreement, the Holder shall not be deemed an Affiliate of the Company or any
of its Subsidiaries. “Affiliates” has a correlative meaning.

 

“Board” means the board of
directors of the Company.

 

“Business Day” means any day
that is not a Saturday, a Sunday or other day on which banks are required or authorized by law to remain closed for the entirety of such
day in New York, New York.

 

“Close of Business” means 5:00
p.m. Eastern Time.

 

“Commission” means the U.S.
Securities and Exchange Commission or any other federal agency then administering the Securities Act or Exchange Act.

 

“Company Common Stock” means
the shares of common stock, par value $0.001 per share, of the Company.

 

“Company Indemnified Persons”
has the meaning set forth in Section 5(a).

 

“Control” means, with respect
to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of such
Person, whether through the ownership of voting securities, by contract or otherwise. “Controlled” has a correlative meaning.

 

“Convertible Note” means the
Convertible Promissory Note issued pursuant to the Securities Purchase Agreement.

 

“Exchange Act” means the Securities
Exchange Act of 1934, as amended.

 

“FINRA” means the Financial
Industry Regulatory Authority.

 

     

     

    

 

“Form S-1 Shelf” has the
meaning set forth in Section 2(a).

 

“Form S-3 Shelf” has the
meaning set forth in Section 2(a).

 

“Holder” has the meaning set
forth in the preamble.

 

“Holder Indemnified Persons”
has the meaning set forth in Section 5(b).

 

“Indemnified Persons” has the
meaning set forth in Section 5(b).

 

“Losses” has the meaning set
forth in Section 5(a).

 

“Parties” has the meaning set
forth in the preamble.

 

“Person” means any individual,
partnership, corporation, company, association, trust, limited liability company, organization, entity or division, or any government,
governmental department or agency or political subdivision thereof.

 

“Proceeding” means any action,
claim, suit, proceeding or investigation (including a preliminary investigation or partial proceeding, such as a deposition) pending
or known to the Company to be threatened.

 

“Prospectus” means the prospectus
included in a Registration Statement (including a prospectus that includes any information previously omitted from a prospectus filed
as part of an effective Registration Statement in reliance upon Rule 430A), all amendments and supplements to the Prospectus, including
post-effective amendments, all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

 

“Registrable Securities” means
(a) any Company Common Stock issuable to the Holder upon conversion of the Convertible Note, (b) any Warrants issuable to the
Holder upon conversion of the Convertible Note, (c) any Company Common Stock issuable to the Holder upon exercise of the Warrants,
(d) any securities issued or issuable with respect to, on account of or in exchange for Company Common Stock described in clauses
(a) and (c), whether by stock split, stock dividend, recapitalization, merger, consolidation or other reorganization, charter amendment
or otherwise, and (e) any options, warrants or other rights to acquire, and any securities received as a dividend or distribution
in respect of, any of the securities described in clauses (a), (b), (c) and (d) above, in each case that are held by the Holder
and its Affiliates or any transferee or assignee of the Holder or its Affiliates, all of which securities are subject to the rights provided
herein until such rights terminate pursuant to the provisions of this Agreement. As to any particular Registrable Securities, such securities
shall not be Registrable Securities when (i) a Registration Statement registering such Registrable Securities under the Securities
Act has been declared effective and such Registrable Securities have been sold, transferred or otherwise disposed of by the Holder thereof
pursuant to such effective Registration Statement, (ii) such Registrable Securities are sold, transferred or otherwise disposed
of pursuant to Rule 144, (iii) such securities cease to be outstanding or (iv) such securities have become eligible for
sale by the Holder pursuant to Rule 144 without any restriction on the volume or manner of such sale and all restrictive legends
and stop transfer instructions have been removed with respect to all book entries representing the applicable Registrable Securities.

 

    2

     

    

 

“Registration Expenses” means
all expenses incurred by the Company in complying with this Agreement, including, without limitation, all registration, qualification
and filing fees, printing expenses, escrow fees, fees and expenses of counsel for the Company and one counsel for the Holder, blue sky
fees and expenses and the expense of any special audits incident to or required by any such registration.

 

“Registration Statement” means
a registration statement of the Company filed with or to be filed with the Commission under the Securities Act that covers the resale
of any of the Registrable Securities pursuant to the provisions of this Agreement, and including any Prospectus, amendments and supplements
to each such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in such registration statement.

 

“Related Person” has the meaning
set forth in Section 9(m).

 

“Representatives” of the Holder
means its partners, shareholders, members, directors, officers, employees, agents, counsel, accountants, consultants, investment advisers
or other professionals or representatives, or its affiliates or wholly owned subsidiaries.

 

“Rule 144” means Rule 144
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.

 

“Rule 405” means Rule 405
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.

 

“Rule 415” means Rule 415
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.

 

“Rule 424” means Rule 424
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.

 

“Rule 430A” means Rule 430A
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.

 

“Seasoned Issuer” means an
issuer eligible to use Form S-3 under the Securities Act and who is not an “ineligible issuer” as defined in Rule 405.

 

“Securities Act” means the
Securities Act of 1933, as amended.

 

“Selling Expenses” means all
underwriting fees, discounts, selling commissions and stock transfer taxes applicable to the sale of Registrable Securities and related
legal and other fees of the Holder not included within the definition of Registration Expenses.

 

    3

     

    

 

“Securities Purchase Agreement”
means that certain Securities Purchase Agreement, dated February 17, 2022, by and between the Company and the Holder, as may be
amended, restated, supplemented or otherwise modified from time to time.

 

“Shelf Period” has the meaning
set forth in Section 2(a).

 

“Shelf Registration” means
the registration of an offering of Registrable Securities on a Form S-1 Shelf or a Form S-3 Shelf, as applicable, on a delayed
or continuous basis under Rule 415, pursuant to Section 2(a).

 

“Shelf Registration Statement”
has the meaning set forth in Section 2(a).

 

“Subsidiary” means, when used
with respect to any Person, any corporation or other entity, whether incorporated or unincorporated, (a) of which such Person or
any other Subsidiary of such Person is a general partner (excluding partnerships, the general partnership interests of which held by
such Person or any Subsidiary of such Person do not have a majority of the voting interests in such partnership) or (b) at least
a majority of the securities or other interests of which having by their terms ordinary voting power to elect a majority of the board
of directors or others performing similar functions with respect to such corporation or other entity is directly or indirectly owned
or controlled by such Person or by any one or more of its Subsidiaries, or by such Person and one or more of its Subsidiaries.

 

“Suspension Period” has the
meaning set forth in Section 2(b).

 

“Trading Market” means the
principal national securities exchange in the United States on which Registrable Securities are (or are to be) listed.

 

“Warrants” means warrants to
purchase Company Common Stock that are issuable upon Conversion of the Convertible Note pursuant to the terms set forth in the Securities
Purchase Agreement.

 

Unless the context requires otherwise: (a) any
pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms; (b) references to Sections,
paragraphs and clauses refer to Sections, paragraphs and clauses of this Agreement; (c) the terms “include,” “includes,”
 “including” or words of like import shall be deemed to be followed by the words “without limitation”; (d) the
terms “hereof,” “herein” or “hereunder” refer to this Agreement as a whole and not to any particular
provision of this Agreement; (e) unless the context otherwise requires, the term “or” is not exclusive and shall have
the inclusive meaning of “and/or”; (f) defined terms herein will apply equally to both the singular and plural forms
and derivative forms of defined terms will have correlative meanings; (g) references to any law or statute shall be deemed to refer
to such law or statute as amended or supplemented from time to time and shall include all rules and regulations and forms promulgated
thereunder, and references to any law, rule, form or statute shall be construed as including any legal and statutory provisions, rules or
forms consolidating, amending, succeeding or replacing the applicable law, rule, form or statute; (h) references to any Person include
such Person’s successors and permitted assigns; and (i) references to “days” are to calendar days unless otherwise
indicated. Each of the Parties hereto acknowledges that each Party was actively involved in the negotiation and drafting of this Agreement
and that no law or rule of construction shall be raised or used in which the provisions of this Agreement shall be construed in
favor or against any Party hereto because one is deemed to be the author thereof.

 

    4

     

    

 

2.            Registration.

 

(a)            Shelf
Registration. No later than ninety (90) days after the date hereof, the Company shall file a Registration Statement for a Shelf Registration
covering the resale of the Registrable Securities with the SEC for an offering to be made on a continuous basis pursuant to Rule 415,
or if Rule 415 is not available for offers and sales of the Registrable Securities, by such other means of distribution of Registrable
Securities as the Holder may reasonably specify (the “Initial Registration Statement”). The Initial Registration Statement
shall be on Form S-3 (or any successor to Form S-3) covering the resale of all of the Registrable Securities held by the Holder
(the “Form S-3 Shelf”), or if the Company is not a Seasoned Issuer at the time of filing, the Company shall file
a Registration Statement for a Shelf Registration on Form S-1 (or any successor to Form S-1) (the “Form S-1 Shelf”
and, together with the Form S-3 Shelf, the “Shelf Registration Statement”). Subject to the terms of this Agreement,
including any applicable Suspension Period, the Company shall cause the Shelf Registration Statement to be declared effective under the
Securities Act as promptly as possible after the filing thereof, but in any event (x) no later than the fifteenth (15th) day following
the filing of the Shelf Registration Statement in the event of no “review” by the Commission, (y) no later than the
sixtieth (60th) day following the filing of the Shelf Registration Statement in the event of “limited review” by the Commission,
or (z) in the event of a “full review” by the Commission, the one hundred and twentieth (120th) day following the filing
of the Shelf Registration Statement (the number of days in (x), (y) and (z) each being a “Review Period,”
depending on the nature of the Commission’s review, and provided, for any days during the period following the initial filing
of the Shelf Registration Statement and prior to the effectiveness of the Shelf Registration Statement that the Commission is unable
to review or declare effective registration statements filed with the Commission due to a shutdown or partial shutdown of the U.S. government
(such days, “Tolled Days”), the applicable number of days in such Review Period shall be extended by the number of
Tolled Days), and shall use its reasonable best efforts to keep such Shelf Registration Statement continuously effective under the Securities
Act until the date that all Registrable Securities covered by such Registration Statement are no longer Registrable Securities, including
(the period during which the Company shall use its reasonable best efforts to keep the Shelf Registration Statement continuously effective
under the Securities Act in accordance with this clause (i), the “Shelf Period”). The Company shall notify the Holder
by e-mail with electronic confirmation of the effectiveness of the Shelf Registration Statement as promptly as practicable, and in any
event within twenty-four (24) hours, after the Company telephonically or otherwise confirms effectiveness with the Commission. The Company
shall file a final Prospectus with the Commission to the extent required by Rule 424. The “Plan of Distribution” section
of such Shelf Registration Statement shall provide for all permitted means of disposition of Registrable Securities, including firm-commitment
underwritten public offerings, agented transactions, sales directly into the market, purchases or sales by brokers and sales not involving
a public offering. Notwithstanding anything to the contrary contained herein, in the event the Commission informs the Company that all
of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering
on a single registration statement, the Company agrees to promptly (A) inform the Holder, (B) file amendments to the Initial
Registration Statement as required by the Commission and/or (C) withdraw the Initial Registration Statement and file a new Registration
Statement (a “New Registration Statement”), in either case covering the maximum number of Registrable Securities permitted
to be registered by the Commission, on Form S-3 or, if the Company is ineligible to register for resale the Registrable Securities
on Form S-3, such other form available to register for resale the Registrable Securities as a secondary offering; provided,
however, that prior to filing such amendment or New Registration Statement, the Company shall be obligated to use its reasonable
efforts to advocate with the Commission for the registration of all of the Registrable Securities. In the event the Company amends the
Initial Registration Statement or files a New Registration Statement, as the case may be, under clauses (B) or (C) above, the
Company will use its reasonable efforts to file with the Commission, as promptly as allowed by the Commission, one or more Registration
Statements on Form S-3 or, if the Company is ineligible to register for resale the Registrable Securities on Form S-3, such
other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration
Statement, as amended, or the New Registration Statement (the “Remainder Registration Statements”).

 

    5

     

    

 

(b)            Suspension
Period. Notwithstanding any other provision of this Section 2, the Company shall have the right, but not the obligation,
to defer the filing of (but not the preparation of), or suspend the use by the Holder of, any Registration Statement for the shortest
period possible, in no event to exceed thirty (30) days (i) upon issuance by the Commission of a stop order suspending the effectiveness
of such Registration Statement with respect to Registrable Securities or the initiation of proceedings with respect to such Registration
Statement under Section 9(d) or 8(e) of the Securities Act; or (ii) if the Company believes in good faith that any
such registration or offering would require the Company (after consultation with external legal counsel), under applicable securities
laws and other laws, to make disclosure of material nonpublic information that would not otherwise be required to be disclosed at that
time that would be materially adverse to the Company (any such period, a “Suspension Period”); provided, that
in no event shall the Company declare Suspension Periods lasting more than 60 days in the aggregate in any twelve (12) month period.
The Company shall (i) give prompt written notice to the Holder of its declaration of a Suspension Period and of the expiration or
termination of the relevant Suspension Period and (ii) promptly resume the process of filing or requesting for effectiveness, or
update the suspended Registration Statement, as the case may be, as may be necessary to permit the Holder to offer and sell its Registrable
Securities in accordance with applicable law.

 

(c)            Required
Information. The Company may require the Holder of Registrable Securities as to which any Registration Statement is being filed or
sale is being effected to furnish to the Company such information regarding the intended method of distribution of such securities and
such other information relating to the Holder and its ownership of Registrable Securities as the Company may from time to time reasonably
request in writing (provided that such information shall be used only in connection with such registration). The Holder agrees
to furnish such information to the Company and to cooperate with the Company as reasonably necessary to enable the Company to comply
with the provisions of this Agreement.

 

(d)            Cessation
of Registration Rights. All registration rights granted under this Section 2 shall continue to be applicable with respect
to the Holder until the Holder no longer holds any Registrable Securities.

 

    6

     

    

 

3.            Registration
Procedures. The procedures to be followed by the Company and the Holder to register the
sale of Registrable Securities pursuant to a Registration Statement in accordance with this Agreement, and the respective rights and
obligations of the Company and the Holder with respect to the preparation, filing and effectiveness of such Registration Statement, are
as follows:

 

(a)            The
Company shall (i) prepare and file a Registration Statement with the Commission (within the time period specified in Section 2(a))
which Registration Statement (A) shall be on a form required by this Agreement (or if not so required, selected by the Company)
for which the Company qualifies, (B) shall be available for the sale of the Registrable Securities in accordance with the intended
method or methods of distribution, and (C) shall comply as to form in all material respects with the requirements of the applicable
form and include and/or incorporate by reference all financial statements required by the Commission to be filed therewith, (ii) use
its reasonable best efforts to cause such Registration Statement to become effective and remain effective for the period provided under
Section 2(a), (iii) use its reasonable best efforts to prevent the occurrence of any event that would cause a Registration
Statement to contain a material misstatement or omission or to be not effective and usable for resale of the Registrable Securities registered
pursuant thereto (during the period that such Registration Statement is required to be effective as provided under Section 2(a)),
and (iv) cause each Registration Statement and the related Prospectus and any amendment or supplement thereto, as of the effective
date of such Registration Statement, amendment or supplement, (x) to comply in all material respects with any requirements of the
Securities Act and the rules and regulations of the Commission and (y) not to contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading (provided,
however, the Company shall have no liability for any information furnished in writing by or on behalf of the Holder to the Company
specifically for inclusion in (including by incorporation by reference) any such Registration Statement that has not been corrected in
a subsequent writing to the Company prior to the filing or other disclosure of such information). The Company will, (1) at least
three (3) Business Days prior to the anticipated filing of a Registration Statement or any related Prospectus or any amendment or
supplement thereto (including any documents incorporated by reference therein), furnish to the Holder and its counsel copies of all such
documents proposed to be filed and make such representatives of the Company as shall be reasonably requested by the Holder available
for discussion of such documents, (2) use its reasonable best efforts to address in each such document prior to being so filed with
the Commission such comments as the Holder or its counsel reasonably shall propose within two (2) Business Days of receipt of such
copies by the Holder and (3) not file any Registration Statement or any related Prospectus or any amendment or supplement thereto
containing information regarding the Holder to which the Holder objects, unless such information is required to comply with any applicable
law or regulation.

 

(b)            The
Company will as promptly as reasonably practicable (i) prepare and file with the Commission such amendments, including post-effective
amendments, and supplements to each Registration Statement and the Prospectus used in connection therewith as (A) may be reasonably
requested by the Holder of Registrable Securities covered by such Registration Statement necessary to permit the Holder to sell in accordance
with its intended method of distribution, including as may be required in connection with any underwritten distribution of Registrable
Securities or (B) may be necessary under applicable law to keep such Registration Statement continuously effective with respect
to the disposition of all Registrable Securities covered thereby for the period provided under Section 2(a) in accordance
with the intended method of distribution and, subject to the limitations contained in this Agreement, prepare and file with the Commission
such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities held
by the Holder, (ii) cause the related Prospectus to be amended or supplemented by any required prospectus supplement, and as so
supplemented or amended, to be filed pursuant to Rule 424, (iii) respond to any comments received from the Commission with
respect to each Registration Statement or Prospectus or any amendment thereto, (iv) as promptly as reasonably practicable, provide
the Holder true and complete copies of all correspondence from and to the Commission relating to such Registration Statement or Prospectus
other than any comments that the Company determines in good faith would result in the disclosure to the Holder of material non-public
information concerning the Company that is not already in the possession of the Holder and (v) enter into such customary agreements
(including, as applicable, underwriting agreements in customary form) and take all such other actions as the Holder the underwriters,
if any, reasonably request in order to expedite or facilitate the disposition of Registrable Securities under such Registration Statement
or Prospectus and otherwise to facilitate, cooperate with and participate in each proposed offering contemplated herein and customary
selling efforts related thereto. The Company will comply in all material respects with the provisions of the Securities Act and the Exchange
Act (including Regulation M under the Exchange Act) with respect to each Registration Statement and the disposition of all Registrable
Securities covered by each Registration Statement.

 

    7

     

    

 

(c)            The
Company will notify the Holder as promptly as practicable: (i)(A) when a Registration Statement, any pre-effective amendment, any
Prospectus or any prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed; (B) when
the Commission notifies the Company whether there will be a “review” of such Registration Statement and whenever the Commission
comments on such Registration Statement (in which case the Company shall provide true and complete copies thereof and all written responses
thereto to the Holder and its counsel, other than information which the Company determines in good faith would constitute material non-public
information that is not already in the possession of the Holder); and (C) with respect to each Registration Statement or any post-effective
amendment thereto, when the same has been declared effective; (ii) of any request by the Commission or any other federal or state
governmental or regulatory authority for amendments or supplements to a Registration Statement or Prospectus or for additional information
(whether before or after the effective date of the Registration Statement) or any other correspondence with the Commission or any such
authority relating to, or which may affect, the Registration Statement; (iii) of the issuance by the Commission or any other governmental
or regulatory authority of any stop order, injunction or other order or requirement suspending the effectiveness of a Registration Statement
covering any or all of the Registrable Securities or preventing or suspending the use of any Prospectus or the initiation or threatening
of any Proceedings for such purpose; (iv) of the receipt by the Company of any notification with respect to the suspension of the
qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or
threatening of any Proceeding for such purpose; or (v) of the occurrence of any event that makes any statement made in such Registration
Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect
or if, as a result of such event or the passage of time, such Registration Statement, Prospectus or other documents requires revisions
so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein (in the
case of the Prospectus, in light of the circumstances under which they were made) not misleading, or if, for any other reason, it shall
be necessary during such time period to amend or supplement such Registration Statement or Prospectus in order to comply with the Securities
Act, which shall correct such misstatement or omission or effect such compliance.

 

(d)            The
Company will use its reasonable best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any stop order
or other order suspending the effectiveness of a Registration Statement, or preventing or suspending the use of any Prospectus, or (ii) any
suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction,
as promptly as practicable, or if any such order or suspension is made effective during any Suspension Period, as promptly as practicable
after the Suspension Period is over.

 

    8

     

    

 

(e)            During
the Shelf Period, upon request of the Holder and without charge, the Company shall furnish to the Holder and its counsel, (i) promptly
after the same is prepared and filed with the SEC, at least one copy of the Registration Statement and any amendment(s) thereto,
including all documents incorporated therein by reference and all exhibits to the extent requested by the Holder or its counsel, (ii) upon
the effectiveness of any amendment(s) to a Registration Statement, a copy of the prospectus included in such Registration Statement
and all amendments and supplements thereto (or such other number of copies as the Holder may reasonably request) and (iii) such
other documents, including copies of any preliminary or final prospectus, as the Holder may reasonably request from time to time in order
to facilitate the disposition of the Registrable Securities owned by the Holder.

 

(f)            The
Company will promptly deliver to the Holder and its counsel as many copies of each Prospectus or Prospectuses (including each form of
prospectus) and each amendment or supplement thereto as the Holder or its counsel may reasonably request in order to facilitate the disposition
of the Registrable Securities by the Holder. The Company hereby consents to the use of such Prospectus and each amendment or supplement
thereto by the Holder in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment
or supplement thereto, so long as the same are used in compliance with the Securities Act and all other applicable laws and regulations.

 

(g)            To
the extent that the Company has certificated shares of Company Common Stock, the Company will cooperate with the Holder to facilitate
the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to a
Registration Statement, which certificates shall be free of all restrictive legends indicating that the Registrable Securities are unregistered
or unqualified for resale under the Securities Act, Exchange Act or other applicable securities laws, and to enable such Registrable
Securities to be in such denominations and registered in such names as the Holder may request in writing. In connection therewith, if
required by the Company’s transfer agent, the Company will promptly, after the effective date of the Registration Statement, cause
an opinion of counsel as to the effectiveness of the Registration Statement to be delivered to and maintained with such transfer agent,
together with any other authorizations, certificates and directions required by the transfer agent which authorize and direct the transfer
agent to issue such Registrable Securities without any such legend upon sale by the Holder of such Registrable Securities pursuant to
the Registration Statement.

 

    9

     

    

 

(h)            Upon
the occurrence of any event contemplated by Section 3(d)(v), as promptly as practicable, the Company will prepare a supplement
or amendment, including a post-effective amendment, if required by applicable law, to the affected Registration Statement or a supplement
to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required
document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus,
in light of the circumstances under which they were made) not misleading, such that the Holder can resume disposition of such Registrable
Securities covered by such Registration Statement or Prospectus.

 

(i)            The
Company will comply with all applicable rules and regulations of the Commission, the Trading Market and FINRA.

 

(j)            The
Holder agrees by its acquisition of Registrable Securities that, upon receipt of a notice from the Company of the occurrence of any event
of the kind described in clauses (ii) through (v) of Section 3(d) or the occurrence of a Suspension Period,
the Holder will forthwith discontinue disposition of such Registrable Securities under the applicable Registration Statement until the
Holder’s receipt of the copies of the supplemental Prospectus or amended Registration Statement or until it is advised in writing
by the Company that the use of the applicable Prospectus may be resumed, and, in either case, has received copies of any additional or
supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus or Registration Statement. In
the event the Company shall give any such notice, the period during which the applicable Registration Statement is required to be maintained
effective shall be extended by the number of days during the period from and including the date of the giving of such notice to and including
the date when the Holder either receives the copies of the supplemented Prospectus or amended Registration Statement or is advised in
writing by the Company that the use of the Prospectus may be resumed.

 

(k)            If
such Registrable Securities are to be sold by any method or in any transaction other than on a national securities exchange or in the
over-the-counter market, in privately negotiated transactions, or in a combination of such methods, the Holder shall notify the Company
at least five (5) Business Days prior to the date on which the Holder first offers to sell any such Registrable Securities.

 

4.            Registration
Expenses. All Registration Expenses incurred in connection with any registration, qualification,
exemption or compliance pursuant to Section 2.1(a) hereof shall be borne by the Company.

 

    10

     

    

 

5.            Indemnification.

 

(a)            To
the fullest extent permitted by law, the Company shall indemnify and hold harmless the Holder, its partners, stockholders, equity holders,
general partners, managers, members and Affiliates and each of their respective officers and directors and any Person who controls the
Holder (within the meaning of the Securities Act or the Exchange Act) and any employee or Representative thereof (each, a “Company
Indemnified Person” and collectively, “Company Indemnified Persons”), from and against any and all losses,
claims, damages, liabilities, joint or several, costs (including reasonable costs of preparation and reasonable attorneys’, accountants’
and experts’ fees) and expenses, judgments, fines, penalties, interest, settlements or other amounts arising from any claims, demands,
actions, suits or proceedings, whether civil, criminal, administrative or investigative, in which any Company Indemnified Person may
be involved, or is threatened to be involved, as a party or otherwise, under the Securities Act, the Exchange Act or otherwise (collectively,
 “Losses”), as incurred, arising out of, based upon, resulting from or relating to (i) any untrue or alleged untrue
statement of a material fact contained in any Registration Statement under which any Registrable Securities were registered, Prospectus
(including in any preliminary prospectus (if used prior to the effective date of such Registration Statement)), or in any summary or
final prospectus or in any amendment or supplement thereto or in any documents incorporated or deemed incorporated by reference in any
of the foregoing or (ii) any omission or alleged omission to state therein a material fact required to be stated therein or necessary
to make the statements made therein (in the case of the Prospectus, in light of the circumstances under which they were made) not misleading,
or (iii) any violation or alleged violation by the Company or any of its Subsidiaries of the Securities Act, the Exchange Act, any
state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any federal, state, foreign
or common law rule or regulation in connection with such Registration Statement, disclosure document or related document or report
or any offering covered by such Registration Statement, and the Company shall reimburse such Company Indemnified Person for any reasonable
legal or other expenses reasonably incurred by it in connection with investigating or defending any such Loss, claim, damage, liability,
demand, action, suit or proceeding (the matters in the foregoing clauses (i) through (iii) being, collectively, “Company
Violations”). Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 5(a):
(A) shall not apply to a Loss by a Company Indemnified Person arising out of or based upon a Company Violation which occurs in reliance
upon and in conformity with information furnished in writing to the Company by the Holder or such Company Indemnified Person expressly
for use in connection with the preparation of such Registration Statement, such preliminary, summary or final prospectus or such amendment
or supplement, or other disclosure document; (B) with respect to any superseded prospectus, shall not inure to the benefit of any
such person from whom the person asserting any such Loss purchased the Registrable Securities that are the subject thereof (or to the
benefit of any other Company Indemnified Person) if the untrue statement or omission of material fact contained in the superseded prospectus
was corrected in the revised prospectus, as then amended or supplemented, if such revised prospectus was timely made available by the
Company pursuant to Section 3(f), and the Company Indemnified Person was promptly advised in writing not to use the incorrect prospectus
prior to the use giving rise to a violation; (C) shall not be available to the extent such Loss is based on a failure of the Holder
to deliver, or to cause to be delivered, the prospectus made available by the Company, if such prospectus was theretofore made available
by the Company pursuant to Section 3(f); and (D) shall not apply to amounts paid in settlement of any Loss if such settlement
is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed.

 

    11

     

    

 

(b)            In
connection with any Registration Statement filed by the Company pursuant to Section 2(a) hereof in which the Holder
has registered for sale its Registrable Securities, the Holder agrees to indemnify and hold harmless, to the fullest extent permitted
by law, the Company, its directors and officers, employees, agents and each Person who controls the Company (within the meaning of the
Securities Act or the Exchange Act) (collectively, “Holder Indemnified Persons,” and together with the Company Indemnified
Persons, each an “Indemnified Person,” and collectively, the “Indemnified Persons”) from and against
any Losses resulting from (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement
under which such Registrable Securities were registered or sold under the Securities Act, Prospectus (including in any preliminary prospectus
(if used prior to the effective date of such Registration Statement)), or in any summary or final prospectus or in any amendment or supplement
thereto or in any documents incorporated by reference in any of the foregoing, (ii) any omission or alleged omission to state therein
a material fact required to be stated therein or necessary to make the statements therein (in the case of the Prospectus, in light of
the circumstances under which they were made) not misleading, or (iii) any violation or alleged violation by the Holder of any federal,
state or common law rule or regulation relating to action or inaction in connection with any information provided by the Holder
in such registration, disclosure document or related document or report in the case of clauses (i) and (ii) to the extent,
but only to the extent, that such untrue statement or omission occurs in reliance upon and in conformity with any information furnished
in writing by or on behalf of the Holder specifically for inclusion in such registration, disclosure document or related document or
report and has not been corrected in a subsequent writing prior to the sale of the Registrable Securities thereunder, and the Holder
will reimburse the Company for any legal or other expenses reasonably incurred by it in connection with investigating or defending such
Losses. In no event shall the liability of the Holder hereunder be greater in amount than the dollar amount of the net proceeds (after
deducting the underwriters’ discounts and commissions) received by the Holder under the sale of Registrable Securities giving rise
to such indemnification obligation.

 

(c)            Any
Indemnified Person under paragraph (a) or (b) of this Section 5 shall (i) give prompt written notice to the
indemnifying person under paragraph (a) or (b) of this Section 5 of any claim with respect to which it seeks indemnification
(provided that any delay or failure to so notify the indemnifying person shall not relieve the indemnifying party of its obligations
hereunder except to the extent, if at all, that the indemnifying person’s ability to defend such claim (through the forfeiture
of substantive rights or defenses) is actually and materially prejudiced by reason of such delay or failure) and (ii) permit such
indemnifying person to assume the defense of such claim with counsel reasonably satisfactory to the Indemnified Person; provided,
however, that any Indemnified Person shall have the right to select and employ separate counsel and to participate in the defense
of such claim, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (A) the indemnifying
person has agreed in writing to pay such fees or expenses, (B) the Indemnified Person has reasonably concluded (based upon advice
of its counsel) that there may be legal defenses available to it or other Indemnified Persons that are different from or in addition
to those available to the indemnifying person, or (C) in the reasonable judgment of any such Indemnified Person (based upon advice
of its counsel) a conflict of interest may exist between such Indemnified Person and the indemnifying person with respect to such claims
(in which case, if the Indemnified Person notifies the indemnifying person in writing that such Indemnified Person elects to employ separate
counsel at the expense of the indemnifying person, the indemnifying person shall not have the right to assume the defense of such claim
on behalf of such Indemnified Person). If any action is settled or if there be a final judgment for the plaintiff, the indemnifying person
agrees to indemnify each Indemnified Person from and against any Losses by reason of such settlement or judgment. No action may be settled
without the written consent of the Indemnified Person, provided that the consent of the Indemnified Person shall not be required
if (x) such settlement includes an unconditional release of such Indemnified Person in form and substance satisfactory to such Indemnified
Person from all liability on the claims that are the subject matter of such settlement; (y) such settlement provides solely for
the payment by the indemnifying person of money as the sole relief for such action and (z) such settlement does not include any
statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. It is understood
that the indemnifying person or persons shall not, except as specifically set forth in this Section 5(c), in connection with
any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements or other charges of
more than one separate firm (in addition to any local counsel that is required to effectively defend against any such proceeding) for
all Indemnified Persons and that all such fees and expenses shall be paid or reimbursed promptly.

 

    12

     

    

 

(d)            If
the indemnification provided for in this Section 5 is held by a court of a competent jurisdiction to be unavailable to an
Indemnified Person with respect to any loss, damage, claim or liability, the indemnifying party, in lieu of indemnifying such Indemnified
Person thereunder, shall to the extent permitted by law, contribute to the amount paid or payable by such Indemnified Person as a result
of such loss, damage, claim or liability in such proportion as is appropriate to reflect the relative fault of the indemnifying party
on the one hand and of the Indemnified Person on the other in connection with the actions that resulted in such loss, claim, damage or
liability, as well as any other relevant equitable considerations. The relative fault of the indemnifying person and of the Indemnified
Person shall be determined by a court of law by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission to state a material fact relates to information supplied by the indemnifying person or Indemnified Person
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Parties agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined
by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in
the immediately preceding sentences. Notwithstanding the provisions of this Section 5(d), the Holder shall not be required
to contribute any amount in excess of the net proceeds (after deducting the underwriters’ discounts and commissions) received by
the Holder under the sale of Registrable Securities giving rise to such indemnification obligation. No Person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty
of such fraudulent misrepresentation.

 

(e)            The
remedies provided for in this Section 5 are not exclusive and shall not limit any rights or remedies which may otherwise
be available to any Indemnified Person at law or in equity. The obligations of the Company and the Holder under this Section 5
shall survive completion of any offering of Registrable Securities pursuant to a Registration Statement and the termination of this
Agreement.

 

    13

     

    

 

6.            Facilitation
of Sales Pursuant to Rule 144. The Company shall timely file the reports required to
be filed by it under the Exchange Act or the Securities Act and the rules adopted by the Commission thereunder (including the reports
under Sections 13 and 15(d) of the Exchange Act referred to in subparagraph (c)(1) of Rule 144), all to the extent required
from time to time to enable the Holder to sell Registrable Securities without registration under the Securities Act within the limitations
of the exemption provided by Rule 144. Upon the written request of the Holder in connection with that Holder’s sale pursuant
to Rule 144, the Company shall deliver to the Holder a written statement as to whether it has complied with such requirements.

 

7.            Registration
Rights Covenant. The Company covenants that it will not, and it will cause its Subsidiaries
not to, grant any right of registration under the Securities Act to any Person other than pursuant to this Agreement, unless the rights
so granted to another Person do not limit or restrict the rights of the Holder hereunder.

 

8.            Miscellaneous.

 

(a)            Remedies.
In the event of a breach by the Company or the Holder of any of its obligations under this Agreement, any Party, in addition to being
entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific
performance of its rights under this Agreement. The Parties agree that monetary damages would not provide adequate compensation for any
losses incurred by reason of a breach by the Company of any of the provisions of this Agreement and further agree that, in the event
of any action for specific performance in respect of such breach, the Company shall waive the defense that a remedy at law would be adequate
and shall waive any requirement for the posting of a bond. No failure or delay by any Person in exercising any right, power or privilege
hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof
or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive
of any rights or remedies provided by law.

 

(b)            Amendment;
Modification; Waivers. This Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed
by the Company and the Holder, which writing shall specifically reference this Agreement, specify the provision(s) hereof that it
is intended to amend or waive and further specify that it is intended to amend or waive such provision(s).

 

(c)            Notices.
All notices and other communications in connection with this Agreement shall be in writing and shall be deemed given if delivered personally,
sent via electronic mail (with confirmation), mailed by registered or certified mail (return receipt requested) or delivered by an express
courier (with confirmation) to the Parties at the following addresses (or at such other address for a Party as may be specified by like
notice):

 

    14

     

    

 

If to the Company:

 

Entasis Therapeutics Holdings Inc.

35 Gatehouse Drive

Waltham, MA 02451

	 	Attn:	Elizabeth Keiley
	 	Tel:	[***]
	 	Email:	[***]

      

with
a copy (which shall not constitute notice) to:

 

Covington & Burling LLP

The New York Times Building

620 Eighth Avenue

New York, NY 10018 

	 	Attn: 	Jack S. Bodner
	 	 	Matthew C. Franker
	 	Tel:  	[***]
	 	 	[***]
	 	Fax:   	[***]
	 	 	[***]
	 	Email: 	[***]
	 	 	[***]

  

If to the Holder:

 

c/o Innoviva, Inc.

1350
Old Bayshore Highway Suite 400

Burlingame, CA 94010

Attention: Marianne Zhen

Email: [***]

 

with
a copy (which shall not constitute notice) to:

Willkie Farr & Gallagher LLP

787 Seventh Avenue

New York, New York 10019 

	 	Attn:	Russell Leaf 
	 	 	Jared Fertman
	 	Tel:	[***]
	 	 	[***]
	 	Email:	[***]
	 	 	[***]

  

    15

     

    

 

(d)            Governing
Law; Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed in accordance with, the laws of the State
of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. In any action or proceeding
between any of the parties arising out of or relating to this Agreement, each of the parties: (a) irrevocably and unconditionally
consents and submits to the exclusive jurisdiction and venue of the Delaware Chancery Court or, to the extent such court does not have
subject matter jurisdiction, the United States District Court sitting in the State of Delaware; (b) agrees that all claims in respect
of such action or proceeding shall be heard and determined exclusively in accordance with clause (a) of this Section 9(d);
(c) waives any objection to laying venue in any such action or proceeding in such courts; (d) waives any objection that
such courts are an inconvenient forum or do not have jurisdiction over any party hereto; and (e) irrevocably and unconditionally
waives the right to trial by jury.

 

(e)            Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective heirs, executors,
administrators, successors, legal representatives and permitted assigns. The Holder may not assign its rights under this Agreement without
the prior written consent of the Company.

 

(f)            Waiver
of Venue. The Parties irrevocably and unconditionally waive, to the fullest extent permitted by applicable law, (i) any objection
that they may now or hereafter have to the laying of venue of any action or proceeding arising out of or relating to this Agreement in
any court referred to in Section 9(d) and (ii) the defense of an inconvenient forum to the maintenance of such
action or proceeding in any such court.

 

(g)            Waiver
of Trial by Jury. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PERSON HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH
PERSON MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT.
EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PERSON HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (ii) SUCH
PERSON UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) SUCH PERSON MAKES THIS WAIVER VOLUNTARILY, AND (iv) SUCH
PERSON HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND EACH ANCILLARY AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION.

 

    16

     

    

 

(h)            Severability.
The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision hereof shall not affect
the validity or enforceability of any other provision. Whenever possible, each provision or portion of any provision of this Agreement
shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement, or the
application thereof to any Person or any circumstance, is invalid or unenforceable, (i) a suitable and equitable provision shall
be substituted therefor to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable
provision and (ii) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall
not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability
of such provision, or the application thereof, in any other jurisdiction; provided, that, if any one or more of the provisions
contained in this Agreement shall be determined to be excessively broad as to activity, subject, duration or geographic scope, it shall
be reformed by limiting and reducing it to the minimum extent necessary, so as to be enforceable under applicable law.

 

(i)            Business
Days. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be
a day other than a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

(j)            Entire
Agreement. This Agreement constitutes the entire agreement among the Parties with respect to the subject matter hereof and supersedes
all prior contracts or agreements with respect to the subject matter hereof and supersedes any and all prior or contemporaneous discussions,
agreements and understandings, whether oral or written, that may have been made or entered into by or among any of the Parties or any
of their respective Affiliates relating to the transactions contemplated hereby.

 

(k)           Execution
of Agreement. This Agreement may be executed and delivered (by facsimile, by electronic mail in Adobe Portable Document Format (.pdf)
or otherwise) in any number of counterparts, each of which, when executed and delivered, shall be deemed an original, and all of which
together shall constitute the same agreement.

 

(l)            Determination
of Ownership. In determining ownership of Company Common Stock hereunder for any purpose, the Company may rely solely on the records
of the transfer agent for the Company Common Stock from time to time, or, if no such transfer agent exists, the Company’s stock
ledger.

 

(m)           No
Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, each Party covenants, agrees and acknowledges
that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against
any of the Company’s or the Holder’s former, current or future direct or indirect equity holders, controlling persons, stockholders,
directors, officers, employees, agents, Affiliates, members, financing sources, managers, general or limited partners or assignees (each,
a “Related Person” and collectively, the “Related Persons”), in each case other than the Company,
the Holder or any of their respective permitted assigns under this Agreement, whether by the enforcement of any assessment or by any
legal or equitable proceeding, or by virtue of any applicable law, it being expressly agreed and acknowledged that no personal liability
whatsoever shall attach to, be imposed on or otherwise be incurred by any of the Related Persons, as such, for any obligation or liability
of the Company or the Holder under this Agreement or any documents or instruments delivered in connection herewith for any claim based
on, in respect of or by reason of such obligations or liabilities or their creation; provided, however, nothing in this
Section 9(m) shall relieve or otherwise limit the liability of the Company or the Holder, as such, for any breach or
violation of its obligations under this Agreement or such agreements, documents or instruments. For the avoidance of doubt, none of the
Parties will have any recourse, be entitled to commence any proceeding or make any claim under this Agreement or in connection with the
transactions contemplated hereby except against any of the Parties or their respective successors and permitted assigns, as applicable.

 

    17

     

    

 

(n)            Third-Party
Beneficiaries. Nothing in this Agreement, express or implied, is intended to confer upon any Person other than a Party and its successors
and permitted assigns any rights, benefits or remedies of any nature whatsoever.

 

(o)            Headings;
Section References; Signatories. All heading references contained in this Agreement are for convenience purposes only and shall
not be deemed to limit or affect any of the provisions of this Agreement.

 

[Signature Pages Follow]

 

    18

     

    

 

IN WITNESS WHEREOF, the undersigned Parties have
executed this Agreement as of the date first written above.

 

	 	ENTASIS THERAPEUTICS HOLDINGS INC.
	 	 
	 	 
	 	By:	/s/ Michael Gutch, Ph.D.
	 	Name:	Michael Gutch, Ph.D.
	 	Title:	Chief Financial and Business Officer
	 	 	 
	 	INNOVIVA STRATEGIC OPPORTUNITIES LLC    
	 	 
	 	By: Innoviva, Inc. (its managing member)
	 	 
	 	By:	/s/ Pavel Raifeld
	 	Name:	Pavel Raifeld
	 	Title:	Chief Executive Officer

 

[Signature Page to Registration Rights
Agreement]Document

Exhibit 4.2

DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934

As of December 31, 2021, Huntington Bancshares Incorporated (“Huntington,” “we,” “our,” “us,” and the “Company”) had three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”):

1)Common Stock, par value $0.01 per share
2)Depositary Shares Each Representing a 1/40th Interest in a Share of 4.500% Series H Non-Cumulative, Perpetual Preferred Stock, par value $0.01 per share
3)Depositary Shares Each Representing a 1/1000th Interest in a Share of 5.70% Series I Non-Cumulative, Perpetual Preferred Stock, par value $0.01 per share

The total number of shares of all classes of stock which the Company has authority to issue is  2,256,617,808, of which 2,250,000,000 shares are classified as Common Stock, par value $0.01 per share, and 6,617,808 shares are classified as Serial Preferred Stock, par value $0.01 per share (the “Serial Preferred Stock”), of which 500,000 shares of Serial Preferred Stock are designated as 4.500% Series H Non-Cumulative, Perpetual Preferred Stock, par value $0.01 per share (the “Series H Preferred Stock”) and 7,000 shares of Serial Preferred Stock are designated as 5.70% Series I Non-Cumulative, Perpetual Preferred Stock, par value $0.01 per share (the “Series I Preferred Stock”).

Shares of Serial Preferred Stock may be issued from time to time in one or more series. Huntington’s board of directors is authorized, within the limitations and restrictions stated in article fifth of Huntington’s charter and pursuant to the Maryland General Corporation Law, to establish the serial designations of the Serial Preferred Stock and any such series (a) may have such voting powers full or limited, or may be without voting powers; (b) may be subject to redemption at such time or times and at such prices; (c) may be entitled to receive dividends or other distributions (which may be cumulative or noncumulative) at such rate or rates, on such conditions, and at such times and payable in preference to, or in such relation to, the dividends or other distributions payable on any other class or classes or series of stock; (d) may have such rights upon the dissolution of, or upon any distribution of the assets of, Huntington; (e) may be made convertible into, or exchangeable for, shares of any other class or classes or of any other series of the same or any other class or classes of stock of Huntington, at such price or prices or at such rates of exchange, and with such adjustments; and (f) shall have such other preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends and other distributions, qualifications, terms or conditions of redemption or other rights, all as are authorized by the board of directors and stated and expressed in the articles supplementary or other charter document providing for the authorization of such Serial Preferred Stock.

A summary of the designations of the authorized and registered classes of Serial Preferred Stock or of any series thereof, and the powers, preferences and relative, participating, optional or other special rights, and qualifications, limitations or restrictions of that stock, or of the authority of Huntington’s board of directors to authorize those designations and other terms, is as follows. For a complete description, we refer you to the Maryland General Corporation Law, our charter and our bylaws.

1)  Description of Common Stock, par value $0.01 per share

Holders of our common stock are entitled to receive dividends when authorized by our board of directors and declared by us out of assets legally available for the payment of dividends. They are also entitled to share ratably in our assets legally available for distribution to our stockholders in the event of our liquidation, dissolution or winding up, or after payment of or adequate provision for all of our known debts and liabilities. These rights are subject to the preferential rights of any other class or series of our stock.

Except as may otherwise be specified in the terms of any class or series of common stock, each outstanding share of common stock entitles the holder to one vote on all matters submitted to a vote of stockholders, including the election of directors. Except as provided with respect to any other class or series of stock, the holders of our common stock will possess the exclusive voting power. There is no cumulative voting in the election of directors, which means that the holders of a majority of the outstanding shares of common stock can elect all of the directors then standing for election, and the holders of the remaining shares will not be able to elect any directors.

Holders of our common stock have no preference, conversion, exchange, sinking fund or redemption rights, have no preemptive rights to subscribe for any of our securities and generally have no appraisal rights except in certain limited transactions. All shares of common stock will have equal dividend, liquidation and other rights. Under Maryland law, our stockholders generally are not liable for our debts or obligations.

Under Maryland law, a Maryland corporation generally cannot dissolve, amend its charter, merge, convert, sell all or substantially all of its assets, engage in a share exchange or engage in similar transactions outside the ordinary course of business, unless declared advisable by the board of directors and approved by the affirmative vote of stockholders holding at least two-thirds of the shares entitled to vote on the matter. However, a Maryland corporation may provide in its charter for approval of these matters by a lesser percentage, but not less than a majority of all of the votes entitled to be cast on the matter. Our charter does not provide for a lesser percentage in these situations.

2)  Depositary Shares Each Representing a 1/40th Interest in a Share of 4.500% Series H Non-Cumulative, Perpetual Preferred Stock, par value $0.01 per share

Description of Series H Preferred Stock

The Series H Preferred Stock ranks, with respect to the payment of dividends and distributions upon liquidation, dissolution or winding-up, (1) on a parity with (i) our Series I Preferred Stock and (ii) each class or series of preferred stock we may issue in the future the terms of which expressly provide that such class or series will rank on a parity with the Series H Preferred Stock as to dividend rights and rights on our liquidation, winding up and dissolution of Huntington and (2) senior to our common stock and each other class or series of stock we may issue in the future the terms of which expressly provide that it ranks junior to the Series H Preferred Stock as to dividend rights and rights on our liquidation, winding-up and dissolution.

The Series H Preferred Stock does not entitle the holder to any preemptive or conversion rights.

Dividends on the Series H Preferred Stock are payable quarterly in arrears, when, as and if authorized by our board of directors and declared by us out of legally available funds, on a non-cumulative basis on the $25,000 per share liquidation preference, at an annual rate equal to 4.500%.

The Series H Preferred Stock is redeemable, in whole or in part, from time to time, at our option on or after April 15, 2026, at a redemption price equal to the liquidation preference, plus any declared and unpaid dividends, without regard to any undeclared dividends. The holders of the Series H Preferred Stock do not have the right to require the redemption or repurchase of the Series H Preferred Stock. The Series H Preferred Stock is also redeemable, in whole but not in part, within 90 days following a regulatory capital treatment event (as defined in our charter) and subject to the prior approval of the Federal Reserve, or other appropriate federal banking agency, at a redemption price equal to the liquidation preference, plus any declared and unpaid dividends, without regard to any undeclared dividends.

Except as indicated below, the holders of the Series H Preferred Stock do not have any voting rights:

•If and when the dividends on the Series H Preferred Stock or on any other class or series of our preferred stock ranking on a parity with the Series H Preferred Stock that has voting rights equivalent to those of the Series H Preferred Stock that are conferred and are exercisable, have not been paid for at least six quarterly dividend periods or more (whether or not consecutive), the holders of the Series H Preferred Stock, together with the holders of all other affected classes and series of preferred stock ranking on a parity with the Series H Preferred Stock, voting as a single class, will be entitled to elect two additional members of our board of directors.

•So long as any shares of the Series H Preferred Stock are outstanding, in addition to any other vote or consent of stockholders required by our charter, the vote or consent of the holders of at least two-thirds of the outstanding shares of the Series H Preferred Stock, voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be necessary for effecting or validating certain charter amendments and certain mergers and consolidations.

Description of Depositary Shares of Series H Preferred Stock

General

The depositary shares represent proportional fractional interests in shares of the Series H Preferred Stock. Each depositary share represents a 1/40th interest in a share of the Series H Preferred Stock and is evidenced by depositary receipts. We have deposited the underlying shares of the Series H Preferred Stock with Computershare Inc. and Computershare Trust Company, N.A., jointly acting as depositary. The holders of depositary shares from time to time are deemed to be parties to the deposit agreement and are bound by all of the terms and conditions thereto by their acceptance of delivery of the depositary shares to the same extent as though they had executed the deposit agreement. Subject to the terms of the deposit agreement, each holder of the depositary shares is entitled, through the depositary, to all the rights and preferences of the Series H Preferred Stock, as applicable, in proportion to the applicable fraction of a share of the Series H Preferred Stock those depositary shares represent.

Dividends and Other Distributions

Each dividend payable on a depositary share is in an amount equal to 1/40th of the dividend declared and payable on the related share of the Series H Preferred Stock.

The depositary will distribute any cash dividends or other cash distributions received in respect of the deposited Series H Preferred Stock to the record holders of depositary shares relating to the underlying Series H Preferred Stock in proportion to the number of depositary shares held by the holders. If we make a distribution other than in cash, the depositary will distribute any securities or property received by it to the record holders of depositary shares entitled to those distributions, unless it determines that the distribution cannot be made proportionally among those holders or that (after consultation with us) it is not feasible to make a distribution, in which case the depositary may, with our approval, adopt a method of distribution that it deems equitable and practicable, including the sale of the securities or property and distribute the net proceeds from the sale to the holders of the depositary shares in proportion to the number of depositary shares they hold.

Record dates for the payment of dividends and other matters relating to the depositary shares are the same as the corresponding record dates for the Series H Preferred Stock.

The amounts distributed to holders of depositary shares are reduced by any amounts required to be withheld by us or the depositary on account of taxes or other governmental charges. The depositary may refuse to make any payment or distribution, or any transfer, exchange, or withdrawal of any depositary shares or the shares of the Series H Preferred Stock until such taxes or other governmental charges are paid.

Redemption of Depositary Shares

If we redeem the Series H Preferred Stock represented by the depositary shares, in whole or in part, the depositary shares will be redeemed with the proceeds received by the depositary resulting from the redemption of the Series H Preferred Stock held by the depositary. The redemption price per depositary share will be equal to 1/40th of the redemption price per share payable with respect to the Series H Preferred Stock, plus any declared and unpaid dividends, without accumulation of undeclared dividends, except in the case of a redemption pursuant to a regulatory capital treatment event (as defined in our charter).

Whenever we redeem shares of the Series H Preferred Stock held by the depositary, the depositary will redeem, as of the same redemption date, the number of depositary shares representing those shares of the Series H Preferred Stock so redeemed. If fewer than all of the outstanding depositary shares are redeemed, the depositary will select the shares to be redeemed pro rata or by lot. The depositary will mail notice of redemption to record holders of the depositary shares not less than 30 and not more than 60 days prior to the date fixed for redemption of the Series H Preferred Stock and the related depositary shares.

Voting the Series H Preferred Stock

Because each depositary share represents a 1/40th interest in a share of the Series H Preferred Stock, holders of depositary shares will be entitled to 1/40th of a vote per depositary share under those limited circumstances in which holders of the Series H Preferred Stock are entitled to a vote.

When the depositary receives notice of any meeting at which the holders of the Series H Preferred Stock are entitled to vote, the depositary will mail the information contained in the notice to the record holders of the depositary shares relating to the Series H Preferred Stock. Each record holder of the depositary shares on the record date, which will be the same date as the record date for the Series H Preferred Stock, may instruct the depositary to vote the amount of the Series H Preferred Stock represented by the holder’s depositary shares. Insofar as practicable, the depositary will vote the amount of the Series H Preferred Stock represented by depositary shares in accordance with the instructions it receives. We will take all reasonable actions that the depositary determines are necessary to enable the depositary to vote as instructed. If the depositary does not receive specific instructions from the holders of any depositary shares representing proportional interests in the Series H Preferred Stock, it will not vote the amount of the Series H Preferred Stock represented by such depositary shares.

Form

The depositary shares were issued in book-entry form through DTC. The Series H Preferred Stock was issued in registered form to the depositary.

Preemptive and Conversion Rights

The holders of the depositary shares do not have any preemptive or conversion rights.

Depositary, Registrar

Computershare Inc. and Computershare Trust Company, N.A., are jointly acting as depositary for the depositary shares, and Computershare Trust Company, N.A. is acting as registrar, dividend disbursing agent and redemption agent.

3)  Description of Depositary Shares Each Representing a 1/1,000th Interest in a Share of 5.70% Series I Non-Cumulative, Perpetual Preferred Stock, par value $0.01 per share

Description of Series I Preferred Stock

The Series I Preferred Stock ranks, with respect to the payment of dividends and distributions upon liquidation, dissolution or winding-up, (1) on a parity with (i) our Series H Preferred Stock and (ii) each class or series of preferred stock we may issue in the future the terms of which expressly provide that such class or series will rank on a parity with the Series I Preferred Stock as to dividend rights and rights on our liquidation, winding up and dissolution of Huntington and (2) senior to our common stock and each other class or series of preferred stock we may issue in the future the terms of which do not expressly provide that it ranks on a parity with or senior to the Series I Preferred Stock as to dividend rights and rights on our liquidation, winding-up and dissolution.

The Series I Preferred Stock does not entitle the holder to any preemptive or conversion rights.

Dividends on the Series I Preferred Stock are payable quarterly in arrears, when, as and if authorized by our board of directors and declared by us out of legally available funds, on a non-cumulative basis on the $25,000 per share liquidation preference, at an annual rate equal to 5.70%.

The Series I Preferred Stock is redeemable, in whole or in part, from time to time, at our option on any dividend payment date on or after December 1, 2022, at a redemption price equal to the liquidation preference, plus any declared and unpaid dividends. The holders of the Series I Preferred Stock do not have the right to require the redemption or repurchase of the Series I Preferred Stock. The Series I Preferred Stock is also redeemable, in whole but not in part, within 90 days following a regulatory capital treatment event (as defined in our charter) at a redemption price equal to the liquidation preference, plus the sum of (i) any authorized, declared and unpaid dividends from the prior dividend period and (ii) the pro-rated portion of dividends, whether or not declared, for the dividend period in which such redemption occurs. Redemption or repurchase of Series I Preferred Stock is subject to receipt of prior approval of the Federal Reserve or other appropriate federal banking agency.

Except as indicated below, the holders of the Series I Preferred Stock do not have any voting rights:

•If and when the dividends on the Series I Preferred Stock or on any other class or series of our preferred stock ranking on a parity with the Series I Preferred Stock that has voting rights equivalent to those of the Series I Preferred Stock, have not been authorized, declared and paid (i) in the case of the Series I Preferred Stock and any class or series of our preferred stock ranking on a parity with the Series I Preferred Stock and bearing non-cumulative dividends, in full for at least six quarterly dividend periods or their equivalent (whether or not consecutive), or (ii) in the case of any class or series of our preferred stock ranking on a parity with the Series I Preferred Stock and bearing cumulative dividends, in an aggregate amount equal to full dividends for at least six quarterly dividend periods or their equivalent (whether or not consecutive), the holders of the Series I Preferred Stock, together with the holders of all other affected classes and series of preferred stock ranking on a parity with the Series I Preferred Stock, voting as a single class, with each series or class having a number of votes proportionate to the aggregate liquidation preference of the outstanding shares of such class or series, will be entitled to elect two additional members of our board of directors.

•So long as any shares of the Series I Preferred Stock are outstanding, in addition to any other vote or consent of stockholders required by our charter, the vote or consent of the holders of at least two-thirds of the outstanding shares of the Series I Preferred Stock and any class or series of preferred stock then outstanding that ranks on a parity with the Series I Preferred Stock and has similar rights, voting together as a single class, with each series or class having a number of votes proportionate to the aggregate liquidation preference of the outstanding shares of such class or series, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be necessary for effecting or validating certain charter amendments and certain mergers and consolidations.

Description of Depositary Shares of Series I Preferred Stock

General

The depositary shares represent proportional fractional interests in shares of the Series I Preferred Stock. Each depositary share represents a 1/1000th interest in a share of our Series I Preferred Stock, and is evidenced by depositary receipts. We have deposited the underlying shares of the Series I Preferred Stock with a depositary pursuant to a deposit agreement among us, Computershare Inc. and Computershare Trust Company, N.A., jointly acting as depositary. The holders of depositary shares from time to time are deemed to be parties to the deposit agreement and are bound by all of the terms and conditions thereto by their acceptance of delivery of the depositary shares to the same extent as though they had executed the deposit agreement. Subject to the terms of the deposit agreement, each holder of the depositary shares is entitled, through the depositary, to all the rights and preferences of the Series I Preferred Stock, as applicable, in proportion to the applicable fraction of a share of Series I Preferred Stock those depositary shares represent.

In this summary, references to “holders” of depositary shares mean those who own depositary shares registered in their own names on the books maintained by the depositary and not indirect holders who own beneficial interests in depositary shares registered in the street name, or issued in book-entry form through DTC.

Dividends and Other Distributions

Each dividend payable on a depositary share is in an amount equal to 1/1000th of the dividend declared and payable on the related share of the Series I Preferred Stock.

The depositary will distribute any cash dividends or other cash distributions received in respect of the deposited Series I Preferred Stock to the record holders of depositary shares relating to the underlying Series I Preferred Stock in proportion to the number of depositary shares held by the holders. If we make a distribution other than in cash, the depositary will distribute any securities or property received by it to the record holders of depositary shares entitled to those distributions, unless it determines that the distribution cannot be made proportionally among those holders or that (after consultation with us) it is not feasible to make a distribution, in which case the depositary may, with our approval, adopt a method of distribution that it deems equitable and practicable, including the sale of the securities or property and distribute the net proceeds from the sale to the holders of the depositary shares in proportion to the number of depositary shares they hold.

Record dates for the payment of dividends and other matters relating to the depositary shares are the same as the corresponding record dates for the Series I Preferred Stock.

The amounts distributed to holders of depositary shares are reduced by any amounts required to be withheld by us or the depositary on account of taxes or other governmental charges. The depositary may refuse to make any payment or distribution, or any transfer, exchange, or withdrawal of any depositary shares or the shares of the Series I Preferred Stock until such taxes or other governmental charges are paid.

Redemption of Depositary Shares

If we redeem the Series I Preferred Stock represented by the depositary shares, in whole or in part, the depositary shares will be redeemed with the proceeds received by the depositary resulting from the redemption of the Series I Preferred Stock held by the depositary. The redemption price per depositary share will be equal to 1/1000th of the redemption price per share payable with respect to the Series I Preferred Stock plus any declared and unpaid dividends, without accumulation of undeclared dividends, except in the case of a redemption pursuant to a regulatory capital treatment event (as defined in our charter).

Whenever we redeem shares of the Series I Preferred Stock held by the depositary, the depositary will redeem, as of the same redemption date, the number of depositary shares representing those shares of the Series I Preferred Stock so redeemed. If fewer than all of the outstanding depositary shares are redeemed, the depositary will select the shares to be redeemed pro rata or by lot. The depositary will mail notice of redemption to record holders of the depositary receipts not less than 30 and not more than 60 days prior to the date fixed for redemption of the Series I Preferred Stock and the related depositary shares.

Voting the Series I Preferred Stock

Because each depositary share represents a 1/1000th interest in a share of the Series I Preferred Stock, holders of depositary receipts will be entitled to 1/1000th of a vote per depositary share under those limited circumstances in which holders of the Series I Preferred Stock are entitled to a vote.

When the depositary receives notice of any meeting at which the holders of the Series I Preferred Stock are entitled to vote, the depositary will mail the information contained in the notice to the record holders of the depositary shares relating to the Series I Preferred Stock. Each record holder of the depositary shares on the record date, which will be the same date as the record date for the Series I Preferred Stock, may instruct the depositary to vote the amount of the Series I Preferred Stock represented by the holder’s depositary shares. Insofar as practicable, the depositary will vote the amount of the Series I Preferred Stock represented by depositary shares in accordance with the instructions it receives. We will take all reasonable actions that the depositary determines are necessary to enable the depositary to vote as instructed. If the depositary does not receive specific instructions from the holders of any depositary shares representing proportional interests in the Series I Preferred Stock, it will not vote the amount of the Series I Preferred Stock represented by such depositary shares.

Form and Notices

The Series I Preferred Stock is issued in registered form to the depositary, and the depositary shares will be issued in book-entry form through DTC. The depositary will forward to the holders of depositary shares all reports, notices, and communications from us that are delivered to the depositary and that we are required to furnish to the holders of the Series I Preferred Stock.

Preemptive and Conversion Rights

The holders of the depositary shares and the Series I Preferred Stock do not have any preemptive or conversion rights.

Depositary, Dividend Disbursing Agent, Registrar and Redemption Agent

Computershare Inc. and Computershare Trust Company, N.A. will be the depositary, and Computershare Trust Company, N.A. will be the dividend disbursing agent, registrar and redemption agent for the depositary shares.

Certain Provisions That May Have an Anti-Takeover Effect

Some of the provisions of Maryland law and our charter and bylaws discussed below could make it more difficult for a third party to acquire us.

We are subject to the Maryland Business Combination Act, which provides that certain business combinations between a Maryland corporation and any interested stockholder (generally any beneficial holder, directly or indirectly, of 10% or more of the voting power of the corporation’s outstanding stock) or its affiliates are prohibited for five years after the most recent date on which the interested stockholder becomes an interested stockholder. After such five-year period, any such business combination is subject to two different supermajority vote requirements. We are also subject to the Maryland Control Share Acquisition Act, which provides that holders of “control shares” of a Maryland corporation acquired in a “control share acquisition” have no voting rights with respect to their control shares except to the extent approved by the affirmative vote of at least two-thirds of the votes entitled to be cast in the election of directors, generally, excluding certain shares of stock. Control shares are voting shares of stock that, if aggregated with all other shares of stock owned by the acquiror or in respect of which the acquiror is able to exercise or direct the exercise of voting power (except solely by virtue of a revocable proxy), would entitle the acquiror to exercise voting power in electing directors within three ranges of voting power, beginning with one-tenth or more.

In addition, the Maryland General Corporation Law permits a Maryland corporation with a class of equity securities registered under the Exchange Act and at least three independent directors to elect to be subject, by provision in its charter or bylaws or a resolution of its board of directors and notwithstanding any contrary provision in the charter or bylaws, to adopt certain takeover defenses without any action by the stockholders of the corporation. We have elected through this provision to require that all vacancies on our board of directors be filled only by the remaining directors, even if such remaining directors do not constitute a quorum. In the future, our board of directors may elect, without stockholder approval, to adopt certain other takeover defenses, including the classification of the board of directors.

Our charter permits our board of directors to authorize, without stockholder approval, the issuance of serial preferred stock from time to time in one or more series with such preferences, conversion or other rights, voting powers, restrictions, limitations as to the dividends, qualifications, terms or conditions of redemption or other rights as permitted by our charter.

Our bylaws provide that a stockholder may nominate individuals for election to our board of directors and propose other business to be considered at an annual or special meeting of stockholders only if such stockholder gives timely notice to our Secretary and complies with the other advance notice procedures, including the provision of specified information, as set forth in our bylaws.

Under Maryland law, a Maryland corporation generally cannot dissolve, amend its charter, merge, convert, sell all or substantially all of its assets, engage in a share exchange or engage in similar transactions outside the ordinary course of business, unless declared advisable by the board of directors and approved by the affirmative vote of stockholders holding at least two-thirds of the shares entitled to vote on the matter. However, a Maryland corporation may provide for in its charter approval of these matters by a lesser percentage, but not less than a majority of all of the votes entitled to be cast on the matter. Our charter does not provide for a lesser percentage in these situations.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}]]